Synaptogenix Inc (SNPX NASDAQ) stock market data APIs
$2.776
0.02(0.7%)
as of March 19, 2025
Synaptogenix Inc Financial Data Overview
Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company. It is conducting clinical and preclinical studies of its lead therapeutic candidate, Bryostatin-1, in Alzheimer's disease. Its preclinical studies have also demonstrated bryostatin's regenerative mechanisms of action for the rare disease Fragile X syndrome, and for other neurodegenerative disorders, such as multiple sclerosis, stroke, and traumatic brain injury. The U.S. Food and Drug Administration has granted Orphan Drug Designation to Synaptogenix for Bryostatin-1 as a treatment for Fragile X syndrome. The company was incorporated in 2012 and is headquartered in New York, New York.
Prev. Close
2.7555
Open
2.776
High
2.8161
Low
2.7545
52 wk Range
2.32-6.217
Market Cap
4 067 K
P/E Ratio
0.2921
Shares Outstanding
1 356 K
EPS
-4.5824
Beta
1.427
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Synaptogenix Inc data using free add-ons & libraries
Get Synaptogenix Inc Fundamental Data
Synaptogenix Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -6 829 012
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-11-27
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Synaptogenix Inc News
New
Orion Capital Management LLC Buys Qualcomm Inc, Distillate U.S. ...
Investment company Orion Capital Management LLC (Current Portfolio) buys Qualcomm Inc, Distillate U.S. Fundamental Stability & Value ETF, Palantir Technologies Inc, Vanguard Short-Term Inflation-Prote...
34 Stocks Moving In Monday's Mid-Day Session
Gainers Valneva SE (NASDAQ: VALN) shares jumped 34.6% to $37.75 after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare. Greenpro Capital Corp. (NAS...
46 Biggest Movers From Yesterday
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical studi...
28 Stocks Moving In Tuesday's Mid-Day Session
Gainers Marine Petroleum Trust (NASDAQ: MARPS) shares jumped 40.5% to $7.17 after gaining 8% on Monday. Bit Digital, Inc. (NASDAQ: BTBT) shares jumped 20.8% to $9.17 amid an increase in the price of...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
